Funding Tracker/ArrayPatch
Seed · Biotech & Drug Discovery · Ireland
ArrayPatch raises €3.2M (USD undisclosed)
Announced November 5, 2026
The round
ArrayPatch announced a Seed round of €3.2M (USD undisclosed) on November 5, 2026. Other participants include WakeUp Capital, Lakeside Capital, DeepIE Ventures, Spark Venture Funding, Dr. Mark Ledwidge.
The SignalArrayPatch announced an additional €1.6 million second close on November 5, 2026, bringing total seed financing to €3.2 million. The total is not €3.2 million of newly raised capital at this close. Proceeds advance DerMap programs toward first-in-human studies. Named participants include WakeUp Capital, Lakeside Capital, DeepIE Ventures, Spark Venture Funding and Dr. Mark Ledwidge. No USD conversion is supplied.
What ArrayPatch does
Dissolving microneedle drug-delivery platform progressing toward first-in-human studies.
ArrayPatch develops DerMap dissolving microneedle therapeutics, including programs for obesity, diabetes and basal cell carcinoma. On November 5, 2026, it announced a €1.6 million second close, bringing its seed financing total to €3.2 million. Proceeds support development toward first-in-human studies. These are development programs, not approved therapies, and no USD conversion is supplied.
Full ArrayPatch profile- Company
- ArrayPatch
- Amount
- €3.2M (USD undisclosed)
- Stage
- Seed
- Announced
- November 5, 2026
- Led by
- Not disclosed
- Other investors
- WakeUp Capital, Lakeside Capital, DeepIE Ventures, Spark Venture Funding, Dr. Mark Ledwidge
- Vertical
- Biotech & Drug Discovery
- Country
- Ireland
- Headquarters
- Cork, Ireland